7 months ago
NBIX
AnalystsPaul MatteisPaul Matteis's Stock Forecasts
AnalystsPaul Matteis
Analyst Ranking
Bottom 15%
#4525 out of 5279 analysts
Average Return
-0.45%
Win Rate
44%41 out of 94
Risk vs Reward
Poor
Good
Paul Matteis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +213.47% | $4.53 | $14.20 | 2024-11-12 - 2025-11-12 | Strong Buy |
Sionna Therapeutics IncSION | +130.34% | $14.80 | $34.09 | 2025-03-03 - 2026-03-03 | Strong Buy |
Maplight Therapeutics IncMPLT | +89.42% | $13.99 | $26.50 | 2025-11-20 - 2026-05-18 | Strong Buy |
Compass Pathways PLCCMPS | +86.99% | $3.92 | $7.33 | 2025-02-26 - 2026-02-26 | Strong Buy |
Lb Pharmaceuticals IncLBRX | +83.22% | $15.14 | $27.74 | 2025-10-05 - 2026-05-18 | Strong Buy |
Paul Matteis Analyst Color
Get additional color on Paul Matteis's coverage of popular stocks
7 months ago
BMRN
Paul Matteis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sionna Therapeutics IncSION | 2 | Strong Buy | $55.00 | +40.16% | Maintains | a day ago |
Definium Therapeutics IncDFTX | 1 | Strong Buy | $30.00 | +46.48% | Initiates Coverage On | a month ago |
Immunic IncIMUX | 1 | Strong Buy | $25.00 | +114.41% | Initiates Coverage On | a month ago |
Lb Pharmaceuticals IncLBRX | 3 | Strong Buy | $40.00 | +44.20% | Maintains | 2 months ago |
Denali Therapeutics IncDNLI | 4 | Strong Buy | $41.00 | +122.83% | Maintains | 2 months ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $42.00 | +56.95% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 7 | Hold | $24.00 | +16.00% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 16 | Hold | $466.00 | +6.74% | Maintains | 3 months ago |
Uniqure NvQURE | 3 | Strong Buy | $40.00 | +60.45% | Maintains | 5 months ago |
Neurocrine Biosciences IncNBIX | 8 | Strong Buy | $188.00 | +19.59% | Maintains | 5 months ago |
Dyne Therapeutics IncDYN | 5 | Strong Buy | $39.00 | +135.79% | Maintains | 5 months ago |
Alnylam Pharmaceuticals IncALNY | 10 | Strong Buy | $508.00 | +77.45% | Maintains | 5 months ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $28.00 | +5.66% | Initiates Coverage On | 6 months ago |
Neumora Therapeutics IncNMRA | 3 | Hold | $3.00 | +69.49% | Maintains | 6 months ago |
Biomarin Pharmaceutical IncBMRN | 11 | Hold | $61.00 | +22.81% | Downgrades | 6 months ago |
Biogen IncBIIB | 7 | Strong Buy | $202.00 | +5.26% | Upgrades | 6 months ago |
Ionis Pharmaceuticals IncIONS | 5 | Hold | $67.00 | -11.20% | Maintains | 7 months ago |
Pepgen IncPEPG | 3 | Strong Buy | $12.00 | +716.33% | Maintains | 8 months ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $94.00 | +8.25% | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 2 | Hold | $8.00 | -0.62% | Downgrades | a year ago |
Gh Research PLCGHRS | 2 | Strong Buy | $32.00 | N/A | Maintains | a year ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | a year ago |
Sage Therapeutics IncSAGE | 5 | Hold | $6.00 | N/A | Maintains | a year ago |
Alector IncALEC | 5 | Hold | $4.00 | N/A | Downgrades | a year ago |
Alto Neuroscience IncANRO | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Neurogene IncNGNE | 2 | Strong Buy | $60.00 | N/A | Maintains | 2 years ago |
Alkermes PLCALKS | 5 | Strong Buy | $36.00 | N/A | Upgrades | 2 years ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 2 years ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Vistagen Therapeutics IncVTGN | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $295.00 | N/A | Maintains | 4 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Strong Buy | $54.00 | N/A | Maintains | 4 years ago |
Leonabio IncLONA | 2 | Hold | $50.00 | N/A | Downgrades | 4 years ago |
Climb Bio IncCLYM | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 5 years ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 5 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 6 years ago |
Gw Pharmaceuticals PLCGWPH | 4 | Hold | $140.00 | N/A | Downgrades | 6 years ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 3 | Buy | $60.00 | N/A | Initiates Coverage On | 8 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $2,280.00 | N/A | Maintains | 8 years ago |
Akcea Therapeutics IncAKCA | 2 | Hold | $31.00 | N/A | Maintains | 8 years ago |
Obseva SaOBSVF | 1 | Buy | $18.00 | N/A | Maintains | 8 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $64.00 | N/A | Maintains | 8 years ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $340.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.